Radiobiology for Children's Health Program, Research Center for Radiation Protection, National Institute of Radiological Sciences, Anagawa 4-9-1, Inage-ku, Chiba 263-8555, Japan.
Toxicol Appl Pharmacol. 2013 Mar 15;267(3):266-75. doi: 10.1016/j.taap.2012.12.024. Epub 2013 Jan 18.
Assessment of risks associated with childhood exposure to ionizing radiation when combined with chemical carcinogens is of great importance. We studied the age-dependence of the effect of combined exposure to ionizing radiation (IR) and a chemical carcinogen on lung carcinogenesis. Female 1-, 5-, and 22-week-old Wistar rats were locally irradiated on the thorax with X-rays (3.18 Gy) and/or were injected intraperitoneally with N-nitrosobis(2-hydroxypropyl)amine (BHP) (1g/kg body weight) 1 week after X-ray exposure or at 23 weeks of age. Rats were terminated at 90 weeks of age. We found that: (i) the incidence of lung tumors (adenoma and adenocarcinoma) increased slightly as a function of age at X-ray exposure, although this was not statistically significant, while the incidence induced by BHP decreased with increasing age at administration; (ii) combined exposure to X-rays at 5 or 22 weeks with BHP 1 week later enhanced the tumor incidence, and the effect at early-life stage (5 weeks irradiation) was more effective than that at late-life stage (22 weeks irradiation); (iii) combined exposure preferentially enhanced malignant transformation; (iv) although a longer interval between the X-ray and BHP treatments reduced the combined effect, risks of early-life irradiation at 1 or 5 weeks of age lasted into adulthood; (v) adenomas and adenocarcinomas induced by X-ray and/or BHP originated from surfactant apoprotein A-positive alveolar type II cells; and (vi), extracellular signal-regulated kinase pathway activation was observed in half the adenocarcinomas, regardless of the exposure schedule. In conclusion, combined exposure may enhance lung tumorigenesis more synergistically at early-life stage (5 weeks of age) than later-life stage.
评估儿童时期接触电离辐射与化学致癌物联合暴露相关的风险非常重要。我们研究了联合暴露于电离辐射(IR)和化学致癌物对肺癌发生的年龄依赖性影响。1 周龄、5 周龄和 22 周龄雌性 Wistar 大鼠在胸部局部用 X 射线(3.18 Gy)照射,并在 X 射线照射后 1 周或 23 周龄时经腹腔内注射 N-亚硝基双(2-羟丙基)胺(BHP)(1g/kg 体重)。大鼠在 90 周龄时处死。我们发现:(i)X 射线照射时的肺肿瘤(腺瘤和腺癌)发生率随年龄的增加而略有增加,但无统计学意义,而 BHP 诱导的发生率随给药年龄的增加而降低;(ii)5 或 22 周龄时联合 X 射线照射和 1 周后 BHP 暴露增强了肿瘤发生率,且早期(5 周照射)的作用比晚期(22 周照射)更有效;(iii)联合暴露优先增强恶性转化;(iv)尽管 X 射线和 BHP 治疗之间的间隔时间延长会降低联合效应,但 1 或 5 周龄时的早期照射风险会持续到成年期;(v)X 射线和/或 BHP 诱导的腺瘤和腺癌起源于表面活性蛋白 A 阳性的肺泡 II 型细胞;(vi),无论暴露方案如何,半数腺癌中均观察到细胞外信号调节激酶通路的激活。总之,联合暴露在生命早期(5 周龄)比生命晚期(22 周龄)更能协同增强肺肿瘤发生。